A significant positive association between HER2 status and hBCATc was observed (Fig. 2) where, HER2 + breast cancer and TNBC subtypes demonstrated higher histopathological grading (p < 0.001) than the other subtypes (Table 1), indicating hBCATc expression is elevated in more aggressive tumours. The gene discussed is ERBB2; the disease is breast carcinoma.